AKT1 and lung carcinoma: In lung cancer treatment, when the PI3K-Akt pathway is inactivated, curcumin (DMC) enhanced the sensitivity of drug-resistant lung cancer cells to cisplatin by downregulating the expression of thymidine phosphorylase and RCC1 [195].